Your session is about to expire
← Back to Search
Indigenous Recovery Planning for Substance Use Disorder
N/A
Waitlist Available
Led By Monica Skewes, PhD
Research Sponsored by Montana State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at time 1, we will assess alcohol and drug use in the 90 days prior to assessment, and each subsequent assessment will measure use in the time since the previous one (approximately 6 weeks).
Awards & highlights
Study Summary
This trial studies how a culturally adapted intervention can help Native Americans with substance use disorder recover. It hopes to reduce health disparities and improve public health for underserved communities.
Who is the study for?
This trial is for American Indian adults living on the Fort Peck reservation who are 18 or older and want help with recovery from Substance Use Disorder. Participants must meet the diagnostic criteria for SUD.Check my eligibility
What is being tested?
The study tests a culturally adapted relapse prevention program called Indigenous Recovery Planning, delivered by trained community members to improve treatment outcomes for substance use disorders among American Indians.See study design
What are the potential side effects?
Since this intervention involves counseling and support rather than medication, traditional side effects associated with drugs are not expected. However, participants may experience emotional discomfort discussing their substance use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at time 1, we will assess alcohol and drug use in the 90 days prior to assessment, and each subsequent assessment will measure use in the time since the previous one (approximately 6 weeks).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time 1, we will assess alcohol and drug use in the 90 days prior to assessment, and each subsequent assessment will measure use in the time since the previous one (approximately 6 weeks).
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent days absent
Secondary outcome measures
Number of substance-related consequences experienced within the past 6 weeks
Other outcome measures
Quality of life score
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment1 Intervention
Receives Indigenous Recovery Planning (IRP) intervention, which includes 6 weekly group intervention sessions lasting about 2 hours each.
Group II: Waitlist Control GroupActive Control1 Intervention
Participants in the waitlist control group do not receive the intervention until after treatment group completes the intervention. Outcomes will be compared between the 2 study arms at baseline and at follow-up, at which point the treatment group will have completed the intervention and the waitlist control group will have not yet been exposed to the intervention, thereby serving as the control group.
Find a Location
Who is running the clinical trial?
Montana State UniversityLead Sponsor
44 Previous Clinical Trials
1,043,684 Total Patients Enrolled
Monica Skewes, PhDPrincipal InvestigatorMontana State University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am an American Indian, 18 or older, living on the Fort Peck reservation and want help for Substance Use Disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Waitlist Control Group
- Group 2: Treatment Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this medical experiment currently open for enrollment?
"Contrary to popular belief, according to clinicaltrials.gov this trial is not presently accepting participants. This study was announced on the 2nd of November 2022 and subsequently updated 9 days later; however, there are 1,394 other studies that are openly recruiting right now."
Answered by AI
Share this study with friends
Copy Link
Messenger